Skip to main content

Table 4 Anthropometric measurements, serum zinc, and IGF 1 of the cholestatic patients before and after zinc supplementation

From: Zinc status in infants and children with cholestatic liver diseases and its effect on growth

VariablesInitialAfter 4 monthsP value
MUAC Z-score (median (IQR), [range])− 1.5 (2), [− 5.9:0.9]1.5 (1.3), [− 3.7:0.6]> 0.05
MUAC percentile (median (IQR), [range])7 (41), [0.00:82]6 (23), [0.00:71]> 0.05
TSF Z-score (median (IQR), [range])− 2.45 (1.8), [− 7.7:0.2]− 2 (2.6), [− 5.09:0.1]> 0.05
TSF percentile (median (IQR), [range])1 (3), [0.00:58]2.5 (21), [0.00:55]> 0.05
Weight Z-score (median (IQR), [range])− 1.2 (1.9), [− 5.5:6.3]− 0.7 (1.9), [− 2.7:94]> 0.05
Weight percentile (median (IQR), [range])11.5 (37), [− 2.7:97]22 (53), [0.00:88]> 0.05
Height (length) Z-score (median (IQR), [range])− 1.6 (2.6), [− 4.8:41]− 0.5 (2.6), [− 2.5:16]0.01*
Height (length) percentile (median (IQR), [range])4 (31), [− 0.23:99]21 (58), [− 0.9:100]0.01*
Serum Zn (mean ± SD) μg/l1252 ± 5572223 ± 10420.001*
IGF-1 (median (IQR), [range]) ng/ml54 (118), [10:780]346 (370), [50:825]0.001*
  1. TSF tricuspid skin fold thickness, mm millimeters, MUAC mid upper arm circumference, cm centimeter, Zn zinc, IGF-1 insulin-like growth factor 1
  2. *P < 0.05 is significant